Tesla, Inc.
372.22USD
-2.3600 (-0.63%)
Not enough data yet
A reading needs 5 members, each at least 14 days old with a track record on this site (simulated portfolios and calls), who shared a take in the last 30 days; 2 of them need a strong record.
Sign in to share your take on TSLA.
Consensus EPS on the street’s adjusted basis, not the filed GAAP figure — which is why the actuals here can differ from the income statement.
| Period | Consensus EPS | 90 days ago | Revisions up (30d) | Revisions down (30d) |
|---|---|---|---|---|
| Current quarter | $0.49▼ | $0.5 | 3 | 5 |
| Next quarter | $0.46▼ | $0.46 | 0 | 4 |
| Current year | $1.77▼ | $1.8 | 4 | 9 |
| Next year | $2.16▼ | $2.22 | 1 | 10 |
Beat in 3 of the last 4
| Quarter | Estimate | Actual | Surprise |
|---|---|---|---|
| 2026-09-30 | $0.45 | $0.48 | +0.03 (+6.4%) |
| 2026-06-30 | $0.54 | $0.33 | -0.21 (-39.2%) |
| 2026-03-31 | $0.35 | $0.41 | +0.06 (+17.1%) |
| 2025-12-31 | $0.45 | $0.5 | +0.05 (+11.0%) |
1,007 ratings from 55 firms
Ratings are attributed to the research firm, not to individual analysts. See every ticker.
| Firm | Action | Rating | Price Target | Date |
|---|---|---|---|---|
| UBS | Maintained | Neutral | $391 $425 | Oct 22, 2026 |
| CLSA | Upgraded from Underperform | Hold | $310 $400 | Oct 22, 2026 |
| Canaccord Genuity | Maintained | Buy | $410 $442 | Oct 22, 2026 |
| Morgan Stanley | Maintained | Equal-Weight | $400 $410 | Oct 22, 2026 |
| BNP Paribas | Upgraded from Underperform | Neutral | $266 $420 | Oct 22, 2026 |
| RBC Capital | Reiterated | Outperform | $480 | Oct 22, 2026 |
| JP Morgan | Maintained | Neutral | $415 $430 | Oct 22, 2026 |
| TD Cowen | Reiterated | Buy | $460 | Oct 22, 2026 |
| Piper Sandler | Maintained | Overweight | $450 $475 | Oct 22, 2026 |
| StoneX | Reiterated | Buy | $475 | Oct 22, 2026 |
| GLJ Research | Reiterated | Sell | $24.86 | Oct 22, 2026 |
| Mizuho | Maintained | Outperform | $450 $460 | Oct 22, 2026 |
| Cantor Fitzgerald | Reiterated | Overweight | $485 | Oct 22, 2026 |
| Needham | Reiterated | Hold | — | Oct 22, 2026 |
| Cantor Fitzgerald | Reiterated | Overweight | $485 | Oct 20, 2026 |
| GLJ Research | Reiterated | Sell | $24.86 | Oct 15, 2026 |
| Jefferies | Maintained | Hold | $350 $400 | Oct 12, 2026 |
| Tigress Financial | Maintained | Buy | $550 | Oct 8, 2026 |
| UBS | Maintained | Neutral | $385 $391 | Oct 7, 2026 |
| JP Morgan | Maintained | Neutral | $445 $415 | Sep 28, 2026 |
| StoneX | Reiterated | Buy | $475 | Sep 25, 2026 |
| Goldman Sachs | Reiterated | Neutral | $360 | Sep 16, 2026 |
| GLJ Research | Reiterated | Sell | $24.86 | Sep 4, 2026 |
| StoneX | Reiterated | Buy | $475 | Sep 3, 2026 |
| GLJ Research | Reiterated | Sell | $24.86 | Aug 18, 2026 |
100 filings from 10 insiders · 8 buy / 8 sell over 6m
Officers and directors of TSLA, from the last two years of filings. Grants, gifts and option exercises are shown but not colour-coded — they are compensation, not a view on the price.
| Insider | Action | Shares | Price | Value | Date |
|---|---|---|---|---|---|
| Taneja VaibhavOfficer, Chief Financial Officer | Sell | 2.6k | $360.13 | $938k | Sep 8, 2026 |
| Taneja VaibhavOfficer, Chief Financial Officer | ExerciseRestricted Stock Unit | 6.5k | — | — | Sep 5, 2026 |
| Taneja VaibhavOfficer, Chief Financial Officer | Exercise | 6.5k | — | — | Sep 5, 2026 |
| TANEJA VAIBHAVChief Financial Officer | Other | 6.5k | — | — | Sep 4, 2026 |
| MUSK ELON REEVEChief Executive Officer | Exercise | 303.96M | $23.34 | $7.09B | Jun 16, 2026 |
| TANEJA VAIBHAVChief Financial Officer | Sell | 2.6k | $402.20 | $1.05M | Jun 8, 2026 |
| TANEJA VAIBHAVChief Financial Officer | Other | 6.5k | — | — | Jun 5, 2026 |
| TANEJA VAIBHAVChief Financial Officer | Sell | 3.0k | $450.00 | $1.35M | May 13, 2026 |
| TANEJA VAIBHAVChief Financial Officer | Exercise | 3.0k | $18.22 | $55k | May 13, 2026 |
| WILSON - THOMPSON KATHLEENDirector | Sell | 26.4k | $369.01 | $9.99M | Apr 30, 2026 |
| WILSON - THOMPSON KATHLEENDirector | Exercise | 40.9k | $14.99 | $614k | Apr 30, 2026 |
| ZHU XIAOTONGOfficer | Exercise | 20.0k | $20.57 | $411k | Mar 31, 2026 |
| WILSON - THOMPSON KATHLEENDirector | Sell | 25.8k | $352.83 | $9.27M | Mar 30, 2026 |
| WILSON - THOMPSON KATHLEENDirector | Exercise | 40.0k | $14.99 | $600k | Mar 30, 2026 |
| TANEJA VAIBHAVChief Financial Officer | Sell | 2.3k | $397.03 | $899k | Mar 6, 2026 |
| TANEJA VAIBHAVChief Financial Officer | Other | 6.5k | — | — | Mar 5, 2026 |
| WILSON - THOMPSON KATHLEENDirector | Sell | 25.7k | $412.46 | $10.69M | Feb 25, 2026 |
| WILSON - THOMPSON KATHLEENDirector | Exercise | 40.0k | $14.99 | $600k | Feb 25, 2026 |
| MURDOCH JAMES RUPERTDirector | Sellindirect | 60.0k | $435.86 | $26.72M | Jan 2, 2026 |
| MUSK ELON REEVEChief Executive Officer | Giftindirect | 210.7k | — | — | Dec 30, 2025 |
No analyst notes on TSLA yet.
Analyst Ratings
39 analysts covering
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Consensus |
|---|---|---|---|---|---|---|
| Current | 4 | 14 | 23 | 2 | 0 | Hold2.53 |
| 1 mo ago | 4 | 15 | 21 | 2 | 2 | Hold2.61 |
| 2 mo ago | 6 | 16 | 20 | 3 | 2 | Hold2.55 |
| 3 mo ago | 6 | 17 | 19 | 4 | 2 | Hold2.56 |
Members whose judged calls on TSLA have played out most reliably.
No settled calls on TSLA yet. Nobody has filed a call with a deadline on it.
A member is listed once they have three judged calls on a name.
A call with a target is judged on whether the price reaches it by the deadline, counting each day's high (a buy) or low (a sell) from the day after the call was made. A call without one is judged on whether the price at the close on the deadline is higher (a buy) or lower (a sell) than the price the call was made at: the live price when it was saved, for a call made with Make a call, or the last close before the day it was filed, for a call made in a note. Not against the market or an index.
A percentage appears once five calls have reached their deadline. A target reached sooner is shown as played out early, and counts toward the percentage when its deadline passes, because a miss cannot be known before then.
A member’s prediction, judged on price history · not investment advice